Myopathy in HIV infection

Handbook of Clinical Neurology

Volumn 85, Issue , 2007, Pages 139-145

  Tien Auh Chan, Adrian ^a   Kirton, Carl ^a   Estanislao, Lydia ^a   Simpson, David M ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67649349576     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0072-9752(07)85010-X     Document Type: Review

References (41)

1. Berman A., Espinoza L.R., Diaz J.D., et al. Rheumatic manifestations of human immunodeficiency virus infection. Am J Med 85 1 (1988) 59-64
2. Bessen L.J., Greene J.B., Louie E., et al. Severe polymyositis-like syndrome associated with zidovudine therapy of AIDS and ARC. N Engl J Med 318 11 (1988) 708
3. Bohan A., and Peter J.B. Polymyositis and dermatomyositis (part 1). N Engl J Med 292 7 (1975) 344-347
4. Bohan A., and Peter J.B. Polymyositis and dermatomyositis (part 2). N Engl J Med 292 8 (1975) 403-407
5. Chalmers A.C., Greco C.M., and Miller R.G. Prognosis in AZT myopathy. Neurology 41 8 (1991) 1181-1184
6. Chariot P., Monnet I., and Gherardi R. Cytochrome c oxidase reaction improves histopathological assessment of zidovudine myopathy. Ann Neurol 34 4 (1993) 561-565
7. Cossarizza A., and Moyle G. Antiretroviral nucleoside and nucleotide analogues and mitochondria. AIDS 18 (2004) 137-151
8. Cote H.C., Brumme Z.L., Craib K.J., et al. Changes in mitochondrial DNA as a marker of nucleotide toxicity in HIV-infected patients. N Engl J Med 346 11 (2002) 811-820
9. Dalakas M.C. Polymyositis, dermatomyositis and inclusion-body myositis. N Engl J Med 325 21 (1991) 1487-1498
10. Dalakas M.C., Pezeshkpour G.H., Gravell M., et al. Polymyositis associated with AIDS retrovirus. JAMA 256 17 (1986) 2381-2383
11. Dalakas M.C., Illa I., Pezeshkpour G.H., et al. Mitochondrial myopathy caused by long-term zidovudine therapy. N Engl J Med 322 16 (1990) 1098-1105
12. Espinoza L.R., Aguilar J.L., Espinoza C.G., et al. Characteristics and pathogenesis of myositis in human immunodeficiency virus infection: distinction from azidothymidine-induced myopathy. Rheum Dis Clin North Am 17 1 (1991) 117-129
13. Estanislao L., Thomas D., and Simpson D. HIV neuromuscular disease and mitochondrial function. Mitochondrion 4 (2004) 131-139
14. Galera C., Redondo C., and Pozo G. Symptomatic hyperlactatemia and lactic acidosis syndrome in HIV patients treated with nucleoside analogue reverse transcriptase inhibitors. First Conference on HIV Pathogenesis and Treatment, Buenos Aires, Argentina 2001 (2001)
15. Gertner E., Thurn J.R., Williams D.N., et al. Zidovudine-associated myopathy. Am J Med 86 6 Pt 2 (1989) 814-818
16. Gonzales M.F., Olney R.K., So Y.T., et al. Subacute structural myopathy associated with human immunodeficiency virus infection. Arch Neurol 45 5 (1988) 585-587
17. Grau J.M., Masanes F., Pedrol E., et al. Human immunodeficiency virus type 1 infection and myopathy: clinical relevance of zidovudine therapy. Ann Neurol 34 2 (1993) 206-211
18. Helbert M., Fletcher T., Peddle B., et al. Zidovudine-associated myopathy. Lancet 2 8612 (1988) 689-690
19. Illa I., Nath A., and Dalakas M. Immunocytochemical and virological characteristics of HIV-associated inflammatory myopathies: similarities with seronegative polymyositis. Ann Neurol 29 5 (1991) 474-481
20. Johnson R., Williams F., Kazi S., et al. Human immunodeficiency virus-associated polymyositis: a longitudinal study of outcome. Arthritis Rheum 49 2 (2003) 172-178
21. Lane R.J., McLean K.A., Moss J., et al. Myopathy in HIV infection: the role of zidovudine and the significance of tubuloreticular inclusions. Neuropathol Appl Neurobiol 19 5 (1993) 406-413
22. Manfredi R., Motta R., Patrono D., et al. A prospective case-control survey of laboratory markers of skeletal muscle damage during HIV disease and antiretroviral therapy. AIDS 16 14 (2002) 1969-1971
23. Manji H., Harrison M.J., Round J.M., et al. Muscle disease, HIV and zidovudine: the spectrum of muscle disease in HIV-infected individuals treated with zidovudine. J Neurol 240 8 (1993) 479-488
24. Marcus K., Truffa M., Boxwell D., et al. Recently identified adverse events secondary to NRTI therapy in HIV-infected individuals: cased from the FDA's adverse event reporting system (AERS) [abstract LB14]. Paper presented at the Ninth Conference on Retroviruses and Opportunistic Infections, Seattle, WA (2002)
25. Mastaglia F.L., and Ojeda V.J. Inflammatory myopathies: Part 1. Ann Neurol 17 3 (1985) 215-227
26. Mastaglia F.L., and Ojeda V.J. Inflammatory myopathies: Part 2. Ann Neurol 17 4 (1985) 317-323
27. Mhiri C., Baudrimont M., Bonne G., et al. Zidovudine myopathy: a distinctive disorder associated with mitochondrial dysfunction. Ann Neurol 29 6 (1991) 606-614
28. Miller K.D., Cameron M., Wood L.V., et al. Lactic acidosis and hepatic steatosis associated with use of stavudine: report of four cases. Ann Intern Med 133 3 (2000) 192-196
29. Mokrzycki M.H., Harris C., May H., et al. Lactic acidosis associated with stavudine administration: a report of five cases. Clin Infect Dis 30 1 (2000) 198-200
30. Morgello S., Wolfe D., Godfrey E., et al. Mitochondrial abnormalities in human immunodeficiency virus-associated myopathy. Acta Neuropathol 90 4 (1995) 366-374
31. Prime K.P., Edwards S.G., Pakianathan M.R., et al. Polymyositis masquerading as mitochondrial toxicity. Sex Transm Infect 79 5 (2003) 417-418
32. Seidman R., Peress N.S., and Nuovo G.J. In situ detection of polymerase chain reaction-amplified HIV-1 nucleic acids in skeletal muscle in patients with myopathy. Mod Pathol 7 3 (1994) 369-375
33. Sellier P., Monsuez J.J., Evans J., et al. Human immunodeficiency virus-associated polymyositis during immune restoration with combination antiretroviral therapy. Am J Med 109 6 (2000) 510-512
34. Simpson D.M., and Bender A.N. Human immunodeficiency virus-associated myopathy: analysis of 11 patients. Ann Neurol 24 1 (1988) 79-84
35. Simpson D.M., and Wolfe D.E. Neuromuscular complications of HIV infection and its treatment. AIDS 5 8 (1991) 917-926
36. Simpson D.M., Citak K.A., Godfrey E., et al. Myopathies associated with human immunodeficiency virus and zidovudine: can their effects be distinguished?. Neurology 43 5 (1993) 971-976
37. Simpson D.M., Slasor P., Dafni U., et al. Analysis of myopathy in a placebo-controlled zidovudine trial. Muscle Nerve 20 3 (1997) 382-385
38. Simpson D.M., Estanislao L., Evans S., et al. HIV-associated neuromuscular weakness syndrome. AIDS 18 10 (2004) 1403-1412
39. Snider W.D., Simpson D.M., Aronyk K.E., et al. Primary lymphoma of the nervous system associated with acquired immune-deficiency syndrome. N Engl J Med 308 1 (1983) 45
40. Snider W.D., Simpson D.M., Nielsen S., et al. Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients. Ann Neurol 14 4 (1983) 403-418
41. Stern R., Gold J., and DiCarlo E.F. Myopathy complicating the acquired immune deficiency syndrome. Muscle Nerve 10 4 (1987) 318-322